XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   102,824,000      
Beginning balance at Dec. 31, 2023 $ 944,618 $ 103 $ 1,031,627 $ (34,739) $ (52,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (2,116,000)      
Repurchase of common stock (114) $ (2) (112)    
Issuance of common stock upon issuance of ESPP (in shares)   557,000      
Issuance of common stock upon issuance of ESPP 2,188   2,188    
Net share settlement of equity awards (in shares)   2,096,000      
Net share settlement of equity awards (7,823) $ 2 (7,825)    
Share-based compensation expense 50,111   50,111    
Other comprehensive (loss) income (5,176)     (5,176)  
Net loss (618,304)       (618,304)
Ending balance (in shares) at Jun. 30, 2024   103,361,000      
Ending balance at Jun. 30, 2024 365,500 $ 103 1,075,989 (39,915) (670,677)
Beginning balance (in shares) at Dec. 31, 2023   102,824,000      
Beginning balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Ending balance (in shares) at Dec. 31, 2024 104,880,048 104,880,000      
Ending balance at Dec. 31, 2024 $ 192,981 $ 105 1,114,550 (32,233) (889,441)
Beginning balance (in shares) at Mar. 31, 2024   101,570,000      
Beginning balance at Mar. 31, 2024 963,474 $ 102 1,057,837 (40,672) (53,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon issuance of ESPP (in shares)   557,000      
Issuance of common stock upon issuance of ESPP 2,188   2,188    
Net share settlement of equity awards (in shares)   1,234,000      
Net share settlement of equity awards (3,530) $ 1 (3,531)    
Share-based compensation expense 19,495   19,495    
Other comprehensive (loss) income 757     757  
Net loss (616,884)       (616,884)
Ending balance (in shares) at Jun. 30, 2024   103,361,000      
Ending balance at Jun. 30, 2024 $ 365,500 $ 103 1,075,989 (39,915) (670,677)
Beginning balance (in shares) at Dec. 31, 2024 104,880,048 104,880,000      
Beginning balance at Dec. 31, 2024 $ 192,981 $ 105 1,114,550 (32,233) (889,441)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon issuance of ESPP (in shares)   558,000      
Issuance of common stock upon issuance of ESPP 389 $ 1 388    
Net share settlement of equity awards (in shares)   2,383,000      
Net share settlement of equity awards (1,035) $ 2 (1,037)    
Share-based compensation expense 19,785   19,785    
Other comprehensive (loss) income (1,117)     (1,117)  
Net loss $ (53,147)       (53,147)
Ending balance (in shares) at Jun. 30, 2025 107,821,415 107,821,000      
Ending balance at Jun. 30, 2025 $ 157,856 $ 108 1,133,686 (33,350) (942,588)
Beginning balance (in shares) at Mar. 31, 2025   105,377,000      
Beginning balance at Mar. 31, 2025 185,671 $ 105 1,125,738 (33,247) (906,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon issuance of ESPP (in shares)   558,000      
Issuance of common stock upon issuance of ESPP 389 $ 1 388    
Net share settlement of equity awards (in shares)   1,886,000      
Net share settlement of equity awards (566) $ 2 (568)    
Share-based compensation expense 8,128   8,128    
Other comprehensive (loss) income (103)     (103)  
Net loss $ (35,663)       (35,663)
Ending balance (in shares) at Jun. 30, 2025 107,821,415 107,821,000      
Ending balance at Jun. 30, 2025 $ 157,856 $ 108 $ 1,133,686 $ (33,350) $ (942,588)